| Literature DB >> 35403076 |
Yingjie Zhao1, Jianping Huang1, Li Zhang1,2, Xinbo Lian1,2, Danfeng Wang1.
Abstract
Entities:
Year: 2022 PMID: 35403076 PMCID: PMC8985403 DOI: 10.1016/j.xinn.2022.100240
Source DB: PubMed Journal: Innovation (N Y) ISSN: 2666-6758
Figure 1The prediction results on Omicron variant
(A) The real development of the COVID-19 pandemic globally (the time period of the COVID-19 data is from January 22, 2020 to February 11, 2022.
(B) The prediction result on the development of COVID-19 from February 2022 to November 2023, in which the green circles represent the real daily new cases globally (January 18, 2022–July 2, 2022), and the blue curve represents the predicted result (January 18, 2022–November 28, 2023). The small plot at the right corner of (B) is the enlarged plot for the predicted result from July 2023 to November 2023.
(C) The prediction results of 6 countries, namely the United States, the United Kingdom, France, Italy, South Korea, and Vietnam. The green circles represent reported cases (January 31, 2022–March 10, 2022), and the blue curve indicates the predicted results.
(D) The prediction results of mainland China and Hong Kong, where the green circles represent the reported cases (mainland China: March 1, 2022–March 24, 2022; Hong Kong: January 29, 2022–March 13, 2022) and the blue line represents the predicted results.